Implementation of an ISBT 128-Compatible Medical Record System to Facilitate Traceability of Stem Cell Products

References (8)

1. International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration. FACT-JACIE Hematopoietic Cellular Therapy Accreditation Manual. 6th ed. Omaha, FACT-JACIE, 2015
2. American Association of Tissue Banks, American Red Cross, American Society for Blood and Marrow Transplantation, American Society for Apheresis, America’s Blood Centers, Foundation for the Accreditation of Cellular Therapy, ICCBBA Inc., International Society for Cellular Therapy, National Marrow Donor Program. Circular of Information for the Use of Cellular Therapy Products. Bethesda, AABB, 2005
3. American Association of Blood. Standards for Cellular Therapy Product Standards, 2nd Edition. Bethesda, AABB, 2007
4. Distler PB. ISBT 128: An internationally standardized means to label cellular therapy products. Pharmaceuticals Policy and Law 2007;9:421-430
5. Distler P. ISBT 128: a global information standard. Cell Tissue Bank 2010;11:365-373
6. International Council for Commonality in Blood Banking Automation. ISBT 128 Standard: Product Coding-Bounded Lists and Definitions, Version 3.3.x. Redlands, ICCBBA, 2007
7. Strong DM, Shinozaki N. Coding and traceability for cells, tissues and organs for transplantation. Cell Tissue Bank 2010;11:305-323
8. Ashford P, Distler P, Gee A, Lankester A, Larsson S, Feller I, Loper K, Pamphilon D, Poston L, Rabe F, Slaper-Cortenbach I, Szczepiorkowski Z, Warkentin P; International Cellular Therapy Coding and Labeling Advisory Group. ISBT 128 implementation plan for cellular therapy products. J Clin Apher 2007;22:258-264.